{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:09:18Z","timestamp":1778875758908,"version":"3.51.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1097\/coc.0b013e31829e19be","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T00:35:53Z","timestamp":1372898153000},"page":"377-381","source":"Crossref","is-referenced-by-count":54,"title":["Cardiac Magnetic Resonance Imaging for the Assessment of the Myocardium After Doxorubicin-based Chemotherapy"],"prefix":"10.1097","volume":"38","author":[{"given":"Matthew A.","family":"Lunning","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelby","family":"Kutty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric T.","family":"Rome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asif","family":"Padiyath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Loberiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Gregory","family":"Bociek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Bierman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K","article-title":". Daunorubicin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.","volume":"20","author":"Tan","year":"1967","journal-title":"Cancer"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/bit.260110607","article-title":". Adriamycin, 14-hydroxydaunorubicin, a new anti-tumor antibiotic from S. peucetius var. caesius.","volume":"11","author":"Arcamone","year":"1969","journal-title":"Biotechnical Bioeng"},{"key":"R3-10-20210128","first-page":"33","article-title":"Adriamycin (NSC-123,127): a new antibiotic with antitumor activity.","volume":"53","author":"DiMarco","year":"1969","journal-title":"Cancer Chemother Rep"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2","article-title":". A clinicopathologic analysis of adriamycin cardiotoxicity.","volume":"32","author":"Lefrak","year":"1973","journal-title":"Cancer"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","article-title":". Risk factors for doxorubicin-induced congestive heart failure.","volume":"91","author":"Von Hoff","year":"1979","journal-title":"Ann Intern Med"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90315-1","article-title":". Daunomycin-induced cardiotoxicity in children and adults: a review of 110 cases.","volume":"62","author":"Von Hoff","year":"1977","journal-title":"Am J Med"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2214\/ajr.184.5.01841420","article-title":". Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease.","volume":"184","author":"Hunold","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10741-006-0232-z","article-title":". Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: Current application and future perspectives.","volume":"11","author":"Gottlieb","year":"2006","journal-title":"Heart Fail Rev"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.1998.16.11.3502","article-title":". Epirubicin cardiotoxicity: an analysis of 469 patients with metastatic breast cancer.","volume":"16","author":"Ryberg","year":"1998","journal-title":"J Clin Oncol"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/1097-0142(19850915)56:6<1361::AID-CNCR2820560624>3.0.CO;2-S","article-title":". Doxorubicin-induced congestive heart failure in adults.","volume":"56","author":"Haq","year":"1985","journal-title":"Cancer"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1200\/JCO.1995.13.11.2827","article-title":". Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia.","volume":"13","author":"Anderlini","year":"1995","journal-title":"J Clin Oncol"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/10428199309087004","article-title":". Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkins disease in adults.","volume":"11","author":"Aviles","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/hrt.81.4.419","article-title":". Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables.","volume":"81","author":"Tjeerdsma","year":"1999","journal-title":"Heart"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/annonc\/mdg070","article-title":". Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkins lymphoma.","volume":"14","author":"Limat","year":"2003","journal-title":"Ann Oncol"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.echo.2008.10.008","article-title":"Identification of anthracycline cardiotoxicity: left ventricular ejection fraction is not enough.","volume":"21","author":"Eidem","year":"2008","journal-title":"J Am Soc Echocardiogram"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1055\/s-2004-813416","article-title":". Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer.","volume":"176","author":"Oberholzer","year":"2004","journal-title":"Rofo"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/MNM.0b013e32834bfec4","article-title":". A prospective comparison of cardiac magnetic resonance imaging and radionuclide ventriculography in the assessment of cardiac function in patients treated with anthracycline-based chemotherapy.","volume":"33","author":"Petri","year":"2012","journal-title":"Nuc Med Commun"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":". Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association.","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-7120-7-53","article-title":". Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar.","volume":"7","author":"Maret","year":"2009","journal-title":"Cardiovascular Ultrasound"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.echo.2012.04.007","article-title":". Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction.","volume":"25","author":"Poterucha","year":"2012","journal-title":"J Am Soc Echocardiogr"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcmg.2009.11.006","article-title":". Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis.","volume":"3","author":"Hor","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2010.194118","article-title":". Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy.","volume":"96","author":"Cheung","year":"2010","journal-title":"Heart"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10554-012-0061-1","article-title":". Reduced global longitudinal and radial strain with normal left ventricular ejection fraction late after effective repair of aortic coarctation: a CMR feature tracking study.","volume":"29","author":"Kutty","year":"2013","journal-title":"Int J Cardiovasc Imaging"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCIMAGING.109.918540","article-title":". Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model.","volume":"3","author":"Lightfoot","year":"2010","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0b013e31829e19be","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:10:10Z","timestamp":1620951010000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201508000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0b013e31829e19be","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}